According to a recent LinkedIn post from Epicore Biosystems, the company is bringing on industry veteran Brian Reagan as its Chief Commercial Officer. The post highlights Reagan’s nearly 30 years of experience leading go-to-market teams across enterprise hardware, software, SaaS, and AI platforms, including roles as CRO and CMO at firms scaling to more than $200M in annual recurring revenue.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Reagan will oversee sales, marketing, partnerships, and customer success as Epicore Biosystems looks to scale its commercial operations around what it describes as a growing “hydration intelligence” opportunity. For investors, this senior-level hire may indicate a shift from primarily technology development toward building a more formalized commercial engine, potentially supporting revenue growth and positioning the company to compete more effectively in digital health and wearable tech markets.
By emphasizing experience in turning technology transitions into “durable, predictable growth,” the post implies a focus on creating repeatable, enterprise-grade sales processes and partnerships. If successfully executed, this strategy could enhance the company’s ability to monetize its connected hydration and hydration science offerings, improve customer retention, and strengthen its long-term valuation prospects in a niche yet expanding segment of digital health.